Asymmetric I-131 uptake in the submandibular gland in the setting of thyroid carcinoma.

I-131 scans may demonstrate asymmetric submandibular signal, secondary to physiologic or pathophysiologic processes. CT correlation may help distinguish metastatic lymphadenopathy from other causes of abnormal uptake. In this report, 2 patients with history of thyroid carcinoma underwent follow-up I-131 scintigraphy. Asymmetric submandibular uptake led to further evaluation with CT. In both cases, the asymmetric uptake was related to alterations of normal physiologic uptake and excretion in the submandibular gland, by different mechanisms. In the first case, excretion was impaired because of chronic obstruction. In the second case, asymmetry was due to chronic disease with impaired function on the contralateral side.

[1]  S. Ilgan,et al.  Unusual patterns of I-131 accumulation. , 2004, Clinical nuclear medicine.

[2]  R. Solans,et al.  Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  Hwan-Jeong Jeong,et al.  Sialolithiasis Mimicking Metastatic Thyroid Cancer , 2000 .

[4]  S. Mandel,et al.  Persistent sialadenitis after radioactive iodine therapy: report of two cases. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  C. Kirsch,et al.  Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  N. Watts,et al.  Sialadenitis Mimicking Metastatic Thyroid Carcinoma , 1989, Clinical nuclear medicine.

[7]  H. Klein,et al.  The Scope of False‐Positive Iodine‐131 Images for Thyroid Carcinoma , 1989, Clinical nuclear medicine.

[8]  G. Braunstein,et al.  Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.